Myriad Genetics, Inc. (MYGN)
Myriad Genetics, Inc. (MYGN) Company Bio
Myriad Genetics discovers and commercializes molecular diagnostic tests that; determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties to improve patient care. The company was founded in 1991 and is based in Salt Lake City, Utah.
MYGN Stock Chart More Charts
MYGN Price/Volume Stats
| Current price | $31.46 |
| Prev. close | $30.91 |
| Day low | $30.50 |
| Day high | $31.65 |
| 50-day MA | $29.35 |
| 200-day MA | $37.62 |
| 52-week high | $50.44 |
| 52-week low | $26.05 |
| Volume | 1,243,754 |
| Avg. volume | 1,017,880 |
| Dividend yield | N/A |
| Market Cap | 2.31B |
MYGN Returns
| 1-mo | 11.48% |
| 3-mo | 0.16% |
| 6-mo | -24.50% |
| 1-year | -5.75% |
| 3-year | -11.21% |
| 5-year | 0.06% |
| YTD | 8.22% |
| 2018 | -15.36% |
| 2017 | 106.03% |
| 2016 | -61.38% |
| 2015 | 26.72% |
| 2014 | 62.35% |
Loading social stream, please wait...